News › Industry News, News

Could the FDA Sunscreen Monograph See a New Addition?

August 29, 2019

The U.S. Food and Drug Administ­ration (FDA) has just published meeting notes in reference to a proposal by DSM Nutritional Products to add the sunscreen bemotrizinol (up to 10%) as a GRASE ingredient to the OTC Sunscreen Monograph.
In the official memorandum, the FDA calls for the submission of specific data to review within seven to nine months (hopefully), and will then issue a final order classifying bemotrizinol (also known as BEMT) as GRASE or not GRASE.Read more at Skin Inc. >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics
    • Glendale Doctor Convicted in $45 Million Botox Fraud Scheme
    • Moxie Announces Treatment Plans
    • Pacific Reliance Medical M&A Advisors Becomes Platinum Vendor Affiliate with the American Med Spa Association